References
Janknegt R, de Marie S, Bakker-Woudenberg IAJM, et al. Liposomal and lipid formulations of amphotericin B. Clin Pharmacokinet 1992; 23: 279–91
Humphreys H, Oliver DA, Winter R, et al. Liposomal amphotericin B and continuous venous-venous haemofiltration. J Antimicrob Chemother 1994; 33: 1071
Tomlin M, Priestley GS. Elimination of liposomal amphotericin by hemodiafiltration. Intensive Care Med 1995; 21: 699–700
Johnson EM, Richardson MD, Warnock DW. In vitro resistance to imidazole antifungals in Candida albicans. J Antimicrob Chemother 1984; 13: 547–58
Granich GG, Kobayashi GS, Krogstad DJ. Sensitive high-pressure liquid chromatographic assay for amphotericin B which incorporates an internal standard. Antimicrob Agents Chemother 1986; 29: 584–8
British Society for Antimicrobial Chemotherapy Working Party. Management of deep Candida infection in surgical and intensive care patients. Intensive Care Med 1994; 20: 522–8
Ambisome Data sheet, Vestar Ltd, Cambridge, UK. ABPI Data Sheet Compendium 1995–96: 1903
de Marie S, Janknegt R, Bakker-Woudenberg IAJM. Clinical use of liposomal and lipid-complexed amphotericin B. J Antimicrob Chemother 1994: 33: 907–16
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Tomlin, M.E., Basarab, A. & Warnock, D.W. Pharmacokinetics of Liposomal Amphotericin B during Haemodiafiltration. Clin. Drug Invest. 13, 118–120 (1997). https://doi.org/10.2165/00044011-199713020-00008
Published:
Issue Date:
DOI: https://doi.org/10.2165/00044011-199713020-00008